Model and social media personality Lottie Moss recently revealed her harrowing experience after taking a high dosage of the medication Ozempic. The 26-year-old younger sister of supermodel Kate Moss shared details about her health scare on her podcast, Dream On.

In the episode released on September 12, Moss disclosed that she had taken Ozempic for two weeks and described the aftermath as the worst she had ever felt. The medication, typically prescribed for Type 2 diabetes, is known to have off-label effects for weight loss and has gained popularity among celebrities.

Moss explained that she obtained Ozempic through a friend, admitting that it was a regrettable decision. Unlike a proper medical consultation, Moss did not undergo the necessary tests or receive medical supervision before starting the drug. At the time, her weight was around 60kg (132lbs).

Initially taking a low dosage, Moss soon escalated her intake, which resulted in two days of severe illness and vomiting. Disturbingly, she experienced a significant and unhealthy weight loss, dropping from 60kg (132lbs) to 53kg (116lbs) in just two weeks.

Faced with dehydration and an inability to keep food or water down, Moss sought medical help and was taken to the emergency room. Disturbingly, while there, she suffered a seizure caused by the dehydration. Moss described the terrifying experience as one of the scariest moments of her life, emphasizing that she would never take the medication again.

Speaking out about her ordeal, Moss hopes to serve as a cautionary tale and educate others about the dangers of pursuing rapid weight loss through medications not prescribed for that purpose. She stressed that Ozempic is primarily intended for diabetes treatment and not for weight loss.

Moss also expressed concern about the current trend of using medications like Ozempic for weight loss, particularly affecting those with eating disorders or struggling with body image issues. The model questioned where the concept of body positivity had gone and urged people to prioritize their health and well-being over societal pressures.

Ozempic, manufactured by Novo Nordisk, mimics the glucagon-like peptide 1 (GLP-1) hormone to regulate blood sugar levels and create a feeling of fullness. However, using the medication improperly can lead to serious complications, including thyroid tumors, pancreatitis, changes in vision, and kidney and gallbladder problems.

The Food and Drug Administration (FDA) has cautioned against the misuse of weight loss medications like Ozempic, Wegovy, and Mounjaro. These drugs, while approved for specific purposes, can cause side effects such as nausea, diarrhea, vomiting, and digestive disorders. More severe complications, including thyroid C-cell tumors, pancreatitis, and increased heart rate, have also been reported.

Moss's story serves as a reminder that responsible medical consultation and supervision are crucial when considering any medication's use, and that chasing rapid weight loss without proper medical oversight can have dire consequences for one's health.